385
Participants
Start Date
December 2, 2016
Primary Completion Date
December 16, 2019
Study Completion Date
December 16, 2019
Amoxicillin
Amoxicillin is an aminopenicillin antibiotic
Amoxicillin-clavulanate
A fixed-ratio combination of amoxicillin trihydrate, an aminopenicillin, and potassium clavulanate, a beta-lactamase inhibitor, used to treat a broad-spectrum of bacterial infections, especially resistant strains.
Cefdinir
Cefdinir is a cephalosporin antibiotic used to treat bacterial infections in many different parts of the body.
Placebo
Placebo
Duke Human Vaccine Institute - Duke Vaccine and Trials Unit, Durham
University of Louisville School of Medicine - Norton Children's Hospital - Infectious Diseases, Louisville
University of Alabama - Children's of Alabama - Infectious Diseases/Virology, Birmingham
Arkansas Children's Hospital - Infectious Diseases, Little Rock
Washington University School of Medicine in St. Louis - Infectious Diseases, St Louis
Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati
Children's Hospital of Philadelphia - The Center for Pediatric Clinical Effectiveness, Philadelphia
Children's Hospital of Pittsburgh of UPMC - General Academic Pediatric, Pittsburgh
Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville
National Institute of Allergy and Infectious Diseases (NIAID)
NIH